Comparative Genomics of Major Clonal Groups of a Lyme Disease Pathogen

莱姆病病原体主要克隆群的比较基因组学

基本信息

  • 批准号:
    8049058
  • 负责人:
  • 金额:
    $ 11.29万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-04-01 至 2012-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Lyme disease is the most prevalent and a fast spreading vector-borne infectious disease in the U.S. It is caused by a spirochetal bacterium Borrelia burgdorferi and transmitted by the deer tick Ixodes scapularis. At least 15 genetically distinct clonal groups of the Lyme disease pathogen are circulating in the northeastern U.S., where over 80% of the Lyme disease cases are reported annually. These clonal groups differ in their wildlife prevalence and human pathogenecity. In 2006, a group of six investigators including the PI have initiated a NIH/NIAID-funded 2-year project producing the whole-genome sequences of 17 B. burgdorferi isolates, with the goal of identifying the genetic basis of clone variations in environmental invasiveness and human virulence. Here, the PI proposes a study to complete the goal of the NIAID whole-genome sequencing project by performing the comparative genome analysis of 12 most common clonal groups. Specific aims are: First, we will identify strain-specific genome changes in a phylogenetic framework. We will identify and align the main chromosomes, orthologous plasmids, and orthologous coding sequences. We will infer a genome-based phylogeny based on chromosomal DNA sequences, so that the strain differences in genome content, genome organization, and DNA sequences can be mapped to different stages during the evolutionary diversification of these clonal groups. Second, we will distinguish more consequential (e.g., adaptive) genomic changes from the lesser (e.g., random) ones by testing for the influence of natural selection. We will identify intergenic sequences important for gene regulation by their sequence conservation, genes critical for B. burgdorferi adaptation (e.g., surface lipoproteins conferring escape from host immunity) by their high non-synonymous nucleotide substitution rates relative to the synonymous rates, genes associated with initial adaptive clonal divergence by comparing the most recently diverged sister clones. Third, we will develop and maintain a website to facilitate the public dissemination of B. burgdorferi comparative genome information, such as genomic changes specific to a high-virulence clonal group. It is unknown why some strains of the Lyme disease bacteria are more pathogenic than others. We will compare the genomes of high- and low-virulence strains to identify the genes contributing to pathogenecity. Virulence-related genome elements are prime targets for designing therapeutics and vaccines.
描述(由申请人提供):莱姆病是美国最流行和传播最快的病媒传染病。它是由螺旋体细菌伯氏疏螺旋体引起的,由鹿蜱肩突硬蜱传播。至少有15个遗传上不同的莱姆病病原体克隆群在美国东北部流行,那里每年报告的莱姆病病例超过80%。这些克隆群体在野生动物流行率和人类致病性方面有所不同。2006年,包括PI在内的六名研究人员发起了一项由NIH/NIAID资助的为期两年的项目,生产17个B的全基因组序列。分离物,目的是确定环境入侵性和人类毒力的克隆变异的遗传基础。在这里,PI提出了一项研究,通过对12个最常见的克隆组进行比较基因组分析,完成NIAID全基因组测序项目的目标。 具体目标是:首先,我们将确定菌株特异性基因组的变化,在系统发育框架。我们将鉴定和比对主要染色体、正向同源质粒和正向同源编码序列。我们将推断基于染色体DNA序列的基因组为基础的同源性,使菌株的基因组内容,基因组组织和DNA序列的差异,可以映射到不同的阶段,这些克隆群体的进化多样化。其次,我们将区分更重要的(例如,适应性的)基因组变化从较小的(例如,随机的)通过测试自然选择的影响。我们将通过序列保守性来鉴定对基因调控重要的基因间序列,即对B至关重要的基因。Burgdorferi适应(例如,赋予逃避宿主免疫的表面脂蛋白),通过比较最近分化的姐妹克隆,发现与初始适应性克隆分化相关的基因。第三,我们会发展和维持一个网站,方便公众发布B。burgdorferi比较基因组信息,如高毒力克隆群特异性的基因组变化。目前还不清楚为什么莱姆病细菌的某些菌株比其他菌株更具致病性。我们将比较高毒力和低毒力菌株的基因组,以确定致病性的基因。与病毒相关的基因组元件是设计治疗剂和疫苗的主要目标。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WEIGANG QIU其他文献

WEIGANG QIU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WEIGANG QIU', 18)}}的其他基金

A PET Radiotracer for Diagnostic and Theranostics Imaging in Lyme Disease
用于莱姆病诊断和治疗成像的 PET 放射性示踪剂
  • 批准号:
    10041529
  • 财政年份:
    2020
  • 资助金额:
    $ 11.29万
  • 项目类别:
Genome Variability and Population Processes of Lyme Disease Pathogens
莱姆病病原体的基因组变异和群体过程
  • 批准号:
    8810213
  • 财政年份:
    2013
  • 资助金额:
    $ 11.29万
  • 项目类别:
Genome Variability and Population Processes of Lyme Disease Pathogens
莱姆病病原体的基因组变异和种群过程
  • 批准号:
    8414170
  • 财政年份:
    2013
  • 资助金额:
    $ 11.29万
  • 项目类别:
Genome Variability and Population Processes of Lyme Disease Pathogens
莱姆病病原体的基因组变异和种群过程
  • 批准号:
    8631038
  • 财政年份:
    2013
  • 资助金额:
    $ 11.29万
  • 项目类别:
Comparative Genomics of Major Clonal Groups of a Lyme Disease Pathogen
莱姆病病原体主要克隆群的比较基因组学
  • 批准号:
    7901198
  • 财政年份:
    2009
  • 资助金额:
    $ 11.29万
  • 项目类别:
Curricular and Pedagogical Innovations in Quantitative Biology
定量生物学的课程和教学创新
  • 批准号:
    8104219
  • 财政年份:
    2008
  • 资助金额:
    $ 11.29万
  • 项目类别:
Comparative Genomics of Major Clonal Groups of a Lyme Disease Pathogen
莱姆病病原体主要克隆群的比较基因组学
  • 批准号:
    7597087
  • 财政年份:
    2008
  • 资助金额:
    $ 11.29万
  • 项目类别:
Comparative Genomics of Major Clonal Groups of a Lyme Disease Pathogen
莱姆病病原体主要克隆群的比较基因组学
  • 批准号:
    7429047
  • 财政年份:
    2008
  • 资助金额:
    $ 11.29万
  • 项目类别:
Curricular and Pedagogical Innovations in Quantitative Biology
定量生物学的课程和教学创新
  • 批准号:
    7645795
  • 财政年份:
    2008
  • 资助金额:
    $ 11.29万
  • 项目类别:
Curricular and Pedagogical Innovations in Quantitative Biology
定量生物学的课程和教学创新
  • 批准号:
    7124126
  • 财政年份:
    2008
  • 资助金额:
    $ 11.29万
  • 项目类别:

相似国自然基金

Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
  • 批准号:
    30801055
  • 批准年份:
    2008
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Synthesis of complex carbohydrate antigens of pathogenic bacteria
病原菌复合糖抗原的合成
  • 批准号:
    RGPIN-2015-05756
  • 财政年份:
    2021
  • 资助金额:
    $ 11.29万
  • 项目类别:
    Discovery Grants Program - Individual
Synthesis of complex carbohydrate antigens of pathogenic bacteria
病原菌复合糖抗原的合成
  • 批准号:
    RGPIN-2015-05756
  • 财政年份:
    2020
  • 资助金额:
    $ 11.29万
  • 项目类别:
    Discovery Grants Program - Individual
Synthesis of complex carbohydrate antigens of pathogenic bacteria
病原菌复合糖抗原的合成
  • 批准号:
    RGPIN-2015-05756
  • 财政年份:
    2019
  • 资助金额:
    $ 11.29万
  • 项目类别:
    Discovery Grants Program - Individual
Synthesis of complex carbohydrate antigens of pathogenic bacteria
病原菌复合糖抗原的合成
  • 批准号:
    RGPIN-2015-05756
  • 财政年份:
    2018
  • 资助金额:
    $ 11.29万
  • 项目类别:
    Discovery Grants Program - Individual
Synthesis of complex carbohydrate antigens of pathogenic bacteria
病原菌复合糖抗原的合成
  • 批准号:
    RGPIN-2015-05756
  • 财政年份:
    2017
  • 资助金额:
    $ 11.29万
  • 项目类别:
    Discovery Grants Program - Individual
Synthesis of complex carbohydrate antigens of pathogenic bacteria
病原菌复合糖抗原的合成
  • 批准号:
    RGPIN-2015-05756
  • 财政年份:
    2016
  • 资助金额:
    $ 11.29万
  • 项目类别:
    Discovery Grants Program - Individual
Synthesis of complex carbohydrate antigens of pathogenic bacteria
病原菌复合糖抗原的合成
  • 批准号:
    RGPIN-2015-05756
  • 财政年份:
    2015
  • 资助金额:
    $ 11.29万
  • 项目类别:
    Discovery Grants Program - Individual
Epidemiological study of serum titers against V-antigens of gram-negative bacteria
革兰阴性菌V抗原血清滴度的流行病学研究
  • 批准号:
    24390403
  • 财政年份:
    2012
  • 资助金额:
    $ 11.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The structure and biosynthesis of glycopeptidolipid antigens from non-tureculous acid-fast bacteria, and their host responses
非结构性抗酸细菌糖肽脂抗原的结构和生物合成及其宿主反应
  • 批准号:
    22590399
  • 财政年份:
    2010
  • 资助金额:
    $ 11.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
display of synthetic antigens on intestinal bacteria based on chemicalbiology and their applications for mucosal vaccines
基于化学生物学的肠道细菌合成抗原展示及其在粘膜疫苗中的应用
  • 批准号:
    21350090
  • 财政年份:
    2009
  • 资助金额:
    $ 11.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了